Bottom line
GGHYX vs XLV: the short answer
GGHYX (INVESCO Health Care Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.
XLV is cheaper at 0.08% vs 0.82% — a difference of $74 a year per $10,000 invested.
Over five years, XLV returned +8.1% a year vs +4.0% for GGHYX.
Updated Nov 19, 2026
GGHYX vs XLV side by side
| GGHYX | XLV | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Invesco | SPDR (State Street) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.82% | 0.08% |
| Annual cost per $10k | $82 | $8 |
| 10-yr cost on $10k (prospectus) | $1,014 | $103 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0.02% |
| 1-yr return | +15.8% | +14.5% |
| 5-yr return (annualized) | +4.0% | +8.1% |
| 10-yr return (annualized) | +6.7% | +9.8% |
| Best quarter | +19.6% | +14.5% |
| Worst quarter | −16.5% | −12.7% |
| Net assets (fund) | $1.2B | $40.6B |
| Number of holdings | 82 | 65 |
| Portfolio turnover | 59% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of GGHYX's top 25 holdings also appear in XLV's top 25.
| Holding | GGHYX | XLV |
|---|---|---|
| Eli Lilly and Co. | 10.59% | 16.51% |
| Johnson & Johnson | 6.76% | 10.64% |
| UnitedHealth Group Inc. | 6.17% | 6.57% |
| Merck & Co., Inc. | 4.59% | 5.52% |
| AbbVie Inc. | 4.03% | 7.74% |
| Gilead Sciences, Inc. | 3.63% | 2.73% |
| CVS Health Corp. | 2.52% | 2.30% |
| Cardinal Health, Inc. | 2.10% | 0.97% |
| Vertex Pharmaceuticals Inc. | 2.01% | 2.19% |
| Thermo Fisher Scientific Inc. | 1.55% | 3.24% |
Source: SEC Form N-PORT
GGHYX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
FAQ
What is the difference between GGHYX and XLV?
GGHYX (INVESCO Health Care Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds. XLV is cheaper at 0.08% vs 0.82% — a difference of $74 a year per $10,000 invested.
Which is cheaper, GGHYX or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both GGHYX and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.